-
Mashup Score: 2Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review - 3 year(s) ago
Gadolinium-based contrast agents (GBCA) improve the diagnostic capabilities of magnetic resonance imaging. Although initially believed to be without major adverse effects, GBCA use in patients with severe chronic kidney disease (CKD) was demonstrated to cause nephrogenic systemic fibrosis (NSF). Restrictive policies of GBCA use in CKD and selective use of GBCAs which bind free gadolinium (Gd+3)…
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events - 4 year(s) ago
October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published in Radiology: Cardiothoracic Imaging.[1] The findings come three years after the European Union enacted new regulations on the contrast agents.
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review - 4 year(s) ago
Gadolinium-based contrast agents (GBCA) improve the diagnostic capabilities of magnetic resonance imaging. Although initially believed to be without major adverse effects, GBCA use in patients with severe chronic kidney disease (CKD) was demonstrated to cause nephrogenic systemic fibrosis (NSF). Restrictive policies of GBCA use in CKD and selective use of GBCAs which bind free gadolinium (Gd+3)…
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 6Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review - 4 year(s) ago
Gadolinium-based contrast agents (GBCA) improve the diagnostic capabilities of magnetic resonance imaging. Although initially believed to be without major adverse effects, GBCA use in patients with severe chronic kidney disease (CKD) was demonstrated to cause nephrogenic systemic fibrosis (NSF). Restrictive policies of GBCA use in CKD and selective use of GBCAs which bind free gadolinium (Gd+3)…
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 2
Gadolinium-based contrast agents (GBCAs) are molecularly heterogeneous with various chelates holding the paramagnetic element gadolinium. Chelates are either linear or macrocyclic, ionic or nonionic (Table 11-5). Historically, nephrologists did not differentiate among these agents. About 2 decades ago, the novel entity nephrogenic systemic fibrosis (NSF) was first reported by Cowper et al6 in…
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 4Gadolinium research should focus on skin, expert says - 4 year(s) ago
Recent evidence in animal studies indicates that gadolinium side effects may be more likely in the skin than the brain, making it important that research into gadolinium deposition swtich its focus to the skin and its innervation, a leading European investigator has suggested.
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 6Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review - 4 year(s) ago
Gadolinium-based contrast agents (GBCA) improve the diagnostic capabilities of magnetic resonance imaging. Although initially believed to be without major adverse effects, GBCA use in patients with severe chronic kidney disease (CKD) was demonstrated to cause nephrogenic systemic fibrosis (NSF). Restrictive policies of GBCA use in CKD and selective use of GBCAs which bind free gadolinium (Gd+3)…
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0Patient tweets show little concern for GBCA retention - 4 year(s) ago
Patients use Twitter to post feedback about their MRI experiences, and although more than 60% of those tweets mention gadolinium-based contrast agents (GBCAs), less than 10% specifically address gadolinium retention, according to a case study published August 18 in the Journal of the American College of Radiology.
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 0
Assess the evolution of gadolinium consumption and magnetic resonance imaging (MRI) scanners in France and Western Brittany (France) and compare regio…
Source: www.sciencedirect.comCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 1Alternatives exist for reduced gadolinium contrast use - 4 year(s) ago
As concerns about the safety of gadolinium-based MRI contrast persist, radiologists should know that they have a number of alternatives to gadolinium, according to presentations on August 9 at the Society for MR Radiographers & Technologists virtual meeting.
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review https://t.co/WicurzjXgD (FREE temporarily) @MichaelRudnick7 @AmandaLeonberg @PennKidney #gadolinium #AKI #CKD #kidneydisease https://t.co/sOocvrl0Sn